Legal notice

 

Website Terms of Use

Access to and use of www.primepharmaceuticals.co.uk is subject to compliance with these terms and conditions of use, as well as laws and regulations in force. Consultation of the website entails implicit acceptance that the terms and conditions of use outlined below will be observed.

NavRax Pharmaceuticals reserves the right, given development of the Internet and applicable law, at any time, and without notice, to: change the terms and conditions of use, by adding or removing these terms and conditions or by supplementing them with special terms and conditions, to modify, edit, delete or to remove information appearing on the website.

 

Access and availability of the site

NavRax Pharmaceuticals cannot be deemed liable for any faults that may lead to the temporary or permanent unavailability of the website or the unavailability of technical connections to it, whether (this not being a limitation) due to an Act of God, maintenance procedures, improvements, modifications, or interventions by the hosting service, a network failure, improper computer configuration or use by the user, or any other type of suspension or interruption of availability to the website.

 

Hyperlinks

This website contains links to other sites on the Internet. These links are intended to facilitate research and guide users to sites likely to provide additional information. However, due to the volatile nature of the information on the Internet and the fact that NavRax Pharmaceuticals cannot control the content of the sites to which a user may be redirected, NavRax Pharmaceuticals cannot be held liable for the content of these sites, nor for any direct or indirect damages incurred as a result of use of third-party sites to which the user has access via links on www.primepharmaceuticals.co.uk.

 

Site content and responsibilities

The information provided by NavRax Pharmaceuticals through this website is provided “as is,” and for information purposes only. NavRax Pharmaceuticals endeavours to include reliable, up-to-date, comprehensive, relevant, legitimate and consistent information, consistent with the regulations in force, but cannot give any guarantee in this respect, and declines any responsibility, insofar as authorized by law, in case of errors or omissions in the content of this website.

This website may contain information relating to public health, opinions expressed by experts, and excerpts from press articles. This information may in no circumstances be used to replace the advice of a health specialist, to make a diagnosis or to determine treatment. Moreover, NavRax Pharmaceuticals will not be held liable for the content of opinions, or the advice, information or references contained in such opinions, and such advice or references cannot be construed as the opinion or responsibility of NavRax Pharmaceuticals.

The user acknowledges that he uses the information on the NavRax Pharmaceuticals site www.primepharmaceuticals.co.uk or obtained via a hyperlink, under his sole responsibility and undertakes to comply with laws and regulations in force while using it.

Even if NavRax Pharmaceuticals is made aware of the fact, it cannot be pursued for any damages, direct or indirect, whatever the causes, origin, nature or consequences resulting, without limitation, (I) from access (or not) to the website, (II) for use of its content on computer equipment belonging to the user (viruses, damage, etc.), (III) for credits given for all or part of the information on this site.

The User agrees to behave in a correct and proper manner, and not comport himself or speak in a manner contrary, in particular, to current regulations and ethical conduct, nor to infringe copyright or cause prejudice to third parties, under pain of being exposed to liability and being excluded from use of the website by NavRax Pharmaceuticals.

 

Intellectual property

This website is a corporate website, operated by NavRax Pharmaceuticals. All of its content, including logos, trademarks, domain names, texts, drawings, presentations, illustrations, photographs, slogans, images, videos and any other work integrated into the website, with the exception of public documents, are the exclusive property of NavRax Pharmaceuticals or third parties having authorized NavRax Pharmaceuticals to use them.

In accordance with Article L122.4 of the Code of Intellectual Property, all representation, reproduction, inclusion, distribution or redistribution, partial or total, is forbidden without prior authorization from the NavRax Pharmaceuticals Communications Division. Unauthorized use shall be considered an infringement which may be pursued, inter alia, under Articles L335-2 of the Code.

Authorized uses (for non-commercial purposes and without modification or alteration of the documents reproduced) must contain information relating to the copyright and ownership of NavRax Pharmaceuticals (Copyright [year] – NavRax Pharmaceuticals – all rights reserved).

 

Privacy and protection of personal data

This website has no information-gathering purpose concerning the confidential data of the user. However certain information may be recorded automatically during visits to www.primepharmaceuticals.co.uk such as, this list being non-exhaustive, the IP address of the user, the Internet address from which the user is connected, the date and time of the visit and the pages visited, the operating system, the browser software and “cookies” that determine how access is performed, when and in what numbers.

Information and data are collected solely for use in providing the services offered and may not be collected or published without the User’s knowledge. Any personal data submitted as part of a communication or in the “recruitment” space will be used for the purpose of responding to the User’s request in the best conditions and according to the Law. However, the User has the option not to provide the requested information, with the understanding that he will not, then, be able to access the requested service, nor complete any forms.

By accessing and using this website and submitting personal data, the User acknowledges understands, accepts and fully agrees to his responsibilities and commitments, as well as those of NavRax Pharmaceuticals.

NavRax Pharmaceuticals attaches the greatest importance to respect for privacy and personal data, and therefore undertakes to respect the confidentiality of personal information gathered from Users visiting this website.

According to Law No. 2004-801 of 6 August 2004 (amending Law No. 78-17 of January 6, 1978) concerning the protection of individuals with regard to the processing of personal data, the User has the right to access, modify, rectify and delete personal data. To do this, the User should send a request by electronic mail, to the Email address listed below:

By post: NavRax Pharmaceuticals – Communications Department – 194 Bureaux de la Colline 92213 Saint Cloud Cedex

Email: info@navrax-pharmaceuticals.com

 

Jurisdiction

The website www.primepharmaceuticals.co.uk and its contents are subject to United Kingdom Law. In case of dispute, only the United Kingdom courts have jurisdiction.

 

Owner and / or Site Editor

NavRax Pharmaceuticals

SAS – Capital: 1,326,566.52 €

SIREN: B311999833 (NANTERRE) APE Code 2120 Z

VAT number: FR 48311999833 Rate: 20%

Address: 194 BUREAUX DE LA COLLINE – 92213, SAINT CLOUD (France)

Phone: +44 (0) 7520 631 193

Email: info@navrax-pharmaceuticals.com

Publishing Director and Managing Editor: NavRax Pharmaceuticals Communications Department

 

Code of ethics and good conduct

We are fully dedicated to achieving high standards of integrity, training, professional skills and respecting national and international regulations.

 

By clicking on this link, you agree to leave our website.
Are you sure?

NO     YES
Picto_Information FREQUENTLY ASKED QUESTIONS Fermer
select products
PRODUCTSREQUESTS
Abtard®
  • Are there bioequivalence data with OxyContin? Fleche bas
  • Yes, data from twelve bioequivalence studies comparing Abtard with the reference product were submitted in support of the application for Marketing Authorisation.
  • How do I store Abtard® tablets? Fleche bas
  • We do not have information on the stability of Abtard® tablets outside of the original packaging. Abtard® tablets must be stored below 25°C in the original packaging to protect from moisture.
  • Is Abtard Monophasic or biphasic? Fleche bas
  • Abtard prolonged -release tablets are bioequivalent to OxyContin prolonged-release tablets and are biphasic, meaning that there is an initial absorption of approximately 40% of oxycodone from the tablet providing onset of analgesia within one hour in most patients, followed by a more controlled absorption, which determines the 12-hour duration or action.
  • How do I take Abtard® tablets? Fleche bas
  • Abtard® tablets must be taken as directed by your doctor or pharmacist. Abtard® tablets must be swallowed whole with a sufficient amount of liquid and not chewed.
  • Are the tablets film coated? Fleche bas
  • Yes they are
  • Are 2 x 60mg tablets bioequivalent to a single 120mg strength of OxyContin? Fleche bas
  • There are no bioequivalence studies for Abtard 2 x 60mg versus one single dose of 120mg of OxyContin.  It is a matter of clinical judgement for the prescriber to decide whether 2 x 60 mg tablets can be used.  What the bioequivalence studies prove is that Abtard 60mg is bioequivalent to OxyContin 60mg.  In practice if a retail pharmacist received a prescription for 120mg of OxyContin and only had the 60mg OxyContin available would they give 2 x 60mg tablets
DIDN'T FIND WHAT YOU WERE LOOKING FOR?
Please feel free to contact us for any further question. Please note that we are unable to provide medical advice.
Contact: medinfo@martindalepharma.co.uk
Picto_Calculette HOW MUCH COULD YOU SAVE ? Fermer
CHOOSE YOUR CCG
TOTAL CCG
SAVINGS across our products
£0.00
CHOOSE A PRACTICE NAME
TOTAL PRACTICE
SAVINGS across our products
£0.00

England & Wales
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in England & Wales by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

NHS Prescription Services, part of the NHS Business Services Authority (BSA), is the provider of the England data and NHS Wales Shared Partnerships Services is the provider of the Wales data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares NavRax Pharmaceuticals products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.

Scotland
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in Scotland by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

ISD, NHS Scotland is the provider of the data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares NavRax Pharmaceuticals products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.